LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
7.73
-0.02 (-0.26%)
At close: May 27, 2026, 4:00 PM EDT
7.83
+0.10 (1.29%)
After-hours: May 27, 2026, 7:08 PM EDT
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$138,086
Profits / Employee
-$717,079
Market Cap
242.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Entrada Therapeutics | 152 |
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Adagene | 128 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
| Cybin | 50 |
LENZ News
- 1 day ago - LENZ Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Lenz Therapeutics price target lowered to $20 from $26 at Citi - TheFly
- 15 days ago - LENZ Therapeutics trading halted, volatility trading pause - TheFly
- 15 days ago - LENZ Therapeutics trading resumes - TheFly
- 15 days ago - Lenz Therapeutics price target raised to $31 from $29 at BofA - TheFly
- 15 days ago - Lenz Therapeutics price target lowered to $38 from $48 at H.C. Wainwright - TheFly
- 15 days ago - Lenz Therapeutics downgraded to Neutral from Overweight at Piper Sandler - TheFly
- 15 days ago - LENZ Therapeutics Q1 Earnings Call Highlights - MarketBeat